NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NYSE · Medical Instruments & Supplies · USD

Stevanato Group S.p.A. (STVN) Stock Analysis

Stevanato Group S.p.A. (STVN) is a Medical Instruments & Supplies stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

STVN

$18.82

−$0.19 (−1.00%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare STVN with… →

STVN Key Statistics

As of Oct 21, 2026
Trading
Open
$18.82
Previous Close
$19.01
Day's Range
18.66–19.18
52-Week Range
12.89–27.99
Volume
408.15K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.78
Valuation
Market Cap
$5.14B
P/E Ratio
33.02
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
22.74
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.36
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
4.20
EPS (ttm)Profit attributable to each share over the last twelve months.
0.57
Financials (FY)
Revenue (FY)
$1.19B+7.45%
Net Income (FY)
$139.84M+18.73%
Profit marginThe share of revenue left as profit after all costs and taxes.
10.99%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
49.83M
1-Year Return
−28.26%
Dividend and dates
Dividend
$0.06+0.32%
Ex-Dividend Date
June 11, 2026
Earnings Date
November 3, 2026
Avg Volume
381.43K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, STVN closed at $18.82, −28.26% over 1 year.

Stevanato Group S.p.A. (STVN) has a market capitalization of $5.14B.

In fiscal 2025, STVN reported revenue of $1.19B.

STVN Stock Return by Calendar Year

Stevanato Group S.p.A. (STVN) return since Jul 2021: what $10,000 became

1 year
$10,000 $7,174
−28.26%
5 years
$10,000 $7,509
−24.91%
Since Jul 2021
$10,000 $9,712
−2.88%

If you had invested $10,000 in Stevanato Group S.p.A. (STVN) at the close on July 16, 2021, the earliest close on record here, it would have been worth $9,712 at the close on October 21, 2026: −2.88% in total, −0.55% a year, with dividends reinvested, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−6.12%
2025−7.41%
2024−19.92%
2023+52.18%
2022−19.66%
2021 (partial year)+14.13%

As of October 21, 2026.

STVN Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$1.19B$139.84M11.8%
2024$1.10B$117.78M10.7%
2023$1.09B$145.63M13.4%
2022$983.68M$142.85M14.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$1.19B$343.88M$198.80M$139.84M11.8%
2024$1.10B$302.32M$161.14M$117.78M10.7%
2023$1.09B$339.89M$200.72M$145.63M13.4%
2022$983.68M$319.80M$192.43M$142.85M14.5%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

STVN Dividend History

$0.06+6.9% vs 2024

Dividends per share, 2025 · 1 payments

YearDividends per sharePaymentsChange
2026*$0.061—
2025$0.061+6.9%
2024$0.061+0.0%
2023$0.061+7.4%
YearDividends per sharePaymentsChange
2026 (partial year)$0.061—
2025$0.061+6.9%
2024$0.061+0.0%
2023$0.061+7.4%
2022$0.051—

Most recent payment: $0.06 per share, ex-dividend June 11, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

STVN Valuation vs Medical Instruments & Supplies Median

Median of 50 stocks
MetricSTVNMedical Instruments & Supplies medianvs median
P/E33.0231.196% above
P/S ratio4.202.6062% above
Profit margin10.99%1.62%9.4 pts above

Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 15 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Stevanato Group S.p.A. (STVN) is capitalised at $5.14B on the latest close. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. Headcount on file is 6,010.

Over the past 52 weeks the price has ranged from $12.89 to $27.99. The most recent close on file for STVN is $18.82, dated October 21, 2026. That is −$0.19 (−1.00%) against the previous close. The latest close sits 46% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $1.19B. Against the prior fiscal year total of $1.10B, that is a change of +7.45%. Net income for the same year was $139.84M. That is +18.73% against the prior fiscal year. The reported profit margin is 10.99%. That is 9.4 percentage points above the Medical Instruments & Supplies median of 1.62%. Earnings per share on a trailing basis come to 0.57.

Across the 4 fiscal years on file, revenue moves from $983.68M in 2022 to $1.19B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 33.02. That is 5.87% above the Medical Instruments & Supplies median of 31.19. On forward earnings the ratio is 22.74. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.36. The price-to-sales ratio is 4.2. On price-to-sales that is 61.5% above the Medical Instruments & Supplies median of 2.6. 50 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

The reported beta is 0.78. Daily returns over the trailing 5 years annualize to a volatility of 49.5%. Over the trailing twelve months the total return is −28.26%. Across 5 years the annualized return works out at −5.57%.

Growth & Income

Shareholders receive a dividend, yielding 0.32% on the latest price. That is 0.7 percentage points below the Medical Instruments & Supplies median yield of 1.04%. The indicated annual rate is $0.06 a share. The ex-dividend date on file is June 11, 2026. Dividends are recorded for 5 calendar years; 2026 shows 1 payments totalling $0.06 a share. The year before, 2025, totalled $0.06 a share.

The strongest complete calendar year on file is 2023 at +52.18%; the weakest is 2024 at −19.92%. Of the 4 complete calendar years on file, 1 finished higher. So far in 2026 the total return is −6.12%.

Peer Comparison

Stevanato Group S.p.A. (STVN) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Stevanato Group S.p.A. STVN $5.14B 33.0
Intuitive Surgical, Inc. ISRG $151.25B 51.8
Becton, Dickinson and Company BDX $52.79B 45.1
Medline Inc. MDLN $47.51B 88.3

The Medical Instruments & Supplies industry average P/E ratio is 31.2x. Stevanato Group S.p.A. trades at a P/E of 33.0.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$151.25B

 BDX

Becton, Dickinson and Company

$52.79B

 MDLN

Medline Inc.

$47.51B

 RMD

ResMed Inc.

$34.63B

 ALC

Alcon Inc.

$32.60B

 WST

West Pharmaceutical Services, Inc.

$27.69B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Stevanato Group S.p.A.

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Visit website →